Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded NK Cell Therapy for Multiple Myeloma
NCT01313897Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Jan 2011
- Primary completion
- Oct 2016
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of expanded natural killer cells in multiple myeloma (MM), sponsored by University of Arkansas. Started Jan 2011; status: completed.
02
Drugs
expanded natural killer cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01313897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313897.